Figure 5.
Overall survival from diagnosis of patients younger than 60 years with acute myeloid leukemia.
Curves are practically identical despite variations in treatment regimens, countries, trial period, population size, and co-operative group. Results from CALGB 922221; ECOG 190022; German AML Cooperative Group23; SWOG 010624; and MRC AML 15.25 Published with permission from Rowe JM. Evaluation of prognostic factors in AML. Best Pract Res Clin Haematol 2011;24:485–8.